Join
Live feed
·
PRReleasevia Quantisnow
Veradermics Incorporated logo

Veradermics to Hold Conference Call to Discuss Topline Results from Phase 2/3 '302' Study of VDPHL01 in Males with Mild-to-Moderate Pattern Hair Loss

ByQuantisnow·Wall Street's wire, on your screen.
MANE· Veradermics Incorporated
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track MANE (Veradermics Incorporated) and more on Quantisnow.